Post by
Chopper1BigDog on Feb 16, 2021 11:43am
Looks Like a good day
Mr. Rebeck was the person responsible for finding the startup money. He did well at that task and allowed LexaGene to perform the research necessary to commercialize a product. He was instrumental in getting the commercialization money and left the company with enough cash for 2021. Although his financial ways caused dilution of the stock price it worked out good for LexaGene. Dr. Regan put his brilliance in the MiQLab technology and design. He also has great business intelligence. He is Thankful for Mr. Rebeck's contribution but knows it is time to push the company forward with a growth strategy. Mr. Mastrocola will bring new financial knowledge to the team. His previous positions at Arthur Andersen and Ernst & Young shows that LexaGene will perform its business by the book and with utmost integrity. It looks like a good strategic move. Still Long and Proud holder of LXXGF!
Comment by
letsdoit on Feb 16, 2021 11:51am
Wrong information given to the board again Chopper, it's not commercialised, that's exactly my point, stop feeding the BS to everyone